Tigereye CTO-Crossing Catheter— 510(k) K201330

Name: FDA 510(k) clearance K201330
Creator: U.S. Food and Drug Administration
Published: 2020-09-10

Substantially Equivalent

Avinger, Inc.

FDA 510(k) clearance K201330 for Tigereye CTO-Crossing Catheter, Substantially Equivalent on 2020-09-10. Applicant: Avinger, Inc.. Device class: 2.

Clearance details

Applicant: Avinger, Inc.
Product code: Code PDU
Device class: Class 2
Regulation: 21 CFR 870.1250
Advisory panel: Cardiovascular
Date received: 2020-05-19
Decision date: 2020-09-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Redwood City, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code PDU

view all

K262013 — Kiba CTO Crossing Catheter2026-08-28
K252315 — Santreva-ATK Endovascular Revasculariztion Catheter2025-09-22
K251158 — PowerWire® 14 Radiofrequency Guidewire Kit2025-09-11
K251376 — LimFlow ARC2025-05-31
K232562 — PowerWire Radiofrequency Guidewire Kit2024-02-28

More clearances from Avinger, Inc.

view all

K230005 — Pantheris LV Atherectomy Catheter2023-06-06
K230594 — Tigereye ST CTO-Crossing Catheter2023-04-25
K212468 — Tigereye CTO-Crossing Catheter2022-01-06
K212047 — Pantheris System2021-11-16
K182341 — Pantheris SV2019-04-09

Adverse events under product code PDU

product code PDU

Malfunction: 793
Total: 793

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.